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Abstract 
 
Introduction 
 
Vertebral body Fat Fraction (FF) has been found to vary between lumbar vertebrae 
using Magnetic Resonance Spectroscopy (MRS).  We aim to more quickly assess a 
larger number of adjacent vertebrae using a single LINEAR In:Out sequence. 
 
Methods 
 
Five males had DEXA and 1.5 Tesla MR scans performed.  MRS was performed at 
L3, and sagittal LINEAR measurements from T10 to S2.  For the LINEAR 
measurements, two independent observers followed a set reading protocol. 
 
Results 
 
For FF measurements there was limited intra-observer variation, with observers 
being on average within 3.4% of the pooled mean value.  Similarly, there was good 
interobserver agreement with an average variation of 2.1%.  All men showed a 
lowering FF between L5-S1 of between 1.6–7%.  Otherwise, there was a trend for 
increasing FF moving inferiorly from T10 to L5.  This averaged 2.7%/vertebra (range 
1.1-3.8%), and appeared to be independent of MRS measured FF at the L3 level.  
Excluding one MRS FF outlier, there was good correlation between MRS FF at L3 
and BMD using DEXA (R2=0.57). 
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Conclusion 
 
LINEAR measurements are largely reproducible between observers following a set 
protocol.  There appears to be a gradient in FF moving from T10 to L5.  This 
variation may better describe overall marrow function than a single vertebral reading. 
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Introduction 
 
Bone marrow contains hematopoietic stem cells, generating circulating blood and 
osteoclasts as well as mesenchymal stem cells which can mature into osteoblasts 
and adipocytes/fat 1 . The ratio of these respective red and yellow cells is not 
constant and changes with age, gender and anatomical location 2, 3. The fat fraction 
(FF) is ratio of fat-to-water-plus-fat and has been determined by magnetic resonance 
spectroscopy (MRS) and imaging (MRI) 3, 4.  Marrow Fraction is the inverse of FF (ie 
100% - FF), and is thought to correlate with marrow function 5.  
 
The FF is known to vary according to anatomical site, as has been demonstrated in 
work with 18F-fluoro-L-deoxythymidine Positron Emission Tomography (FLT-PET) 
imaging 6. This group reported high FF in cervical spine, lowest FF in the thoracic 
spine and lumbar spine decreasing again in the sacrum. However, PET/CT studies 
are not suitable for repeated measures or acquiring normative data due to the 
radiation exposure. Early experience measuring FF via MRS at two separate lumbar 
vertebrae showed increasing FF for the more inferior vertebra 3.  This observation is 
consistent with a later report assessing the four vertebrae from L1 to L4, showing the 
same trend, even between neighbouring vertebrae 2.  It is therefore plausible that a 
point estimate of FF in a single vertebra doesn’t completely describe marrow 
function.  A more comprehensive measurement of not only FF but also change in FF 
according to anatomical site and time may provide a more complete description. 
 
Preliminary work suggests there is a correlation between the Fat Fraction (FF) 
estimated by Magnetic Resonance Spectroscopy (MRS) in Lumbar vertebrae and 
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the accepted standard of Bone Mineral Density (BMD) measured by DEXA 7.  
However, there is a wide degree of overlap between subjects classified as normal, 
osteopaenic and osteoporotic on DEXA and their corresponding FF values.  Some of 
this variability would be explained by clinical factors such as age and gender 4, which 
are routinely incorporated into fracture risk nomograms such as FRAX 8.  However, 
due to the complex physiology of bone beyond what can be quantified through DEXA 
imaging and clinical parameters, it is plausible that some of this variability may be 
due to other factors which MRI would be well placed to assess. 
 
The LINEAR In:Out Phase image sequences produce separate water and fat only 
images, and have previously been shown to correlate very strongly with MRS 
derived FF measurements in bone 3, and liver 9. The advantage of imaging 
approaches applied to a sagittal section of vertebrae is that the FF can be estimated 
for a larger number of structures in a much shorter time than performing MRS in 
multiple Regions of Interest (ROI).  We aim to use the LINEAR In:Out sequence in a 
group of older male patients entering onto a clinical trial investigating the effects of 
androgen deprivation on marrow function.   
 
Evaluation of normal and pathological changes in bone marrow FF preferably 
requires non-invasive methods that do not require x-rays or radiotracers. The 
variation of FF along the vertebral column suggests the requirement of assessing a 
large a range of the spine as possible.  MRI methods including In:Out phase imaging 
as investigated in this study show great promise in this regard.    
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Methods 
 
Participants 
 
Eligible patients were men with localized prostate cancer who were to receive 
androgen deprivation therapy (ADT) and prostate radiotherapy.  None had a history 
of lower back problems.  Screening thoracolumbar X-Rays were performed exclude 
oestoporotic compression fractions, advanced degenerative changes or any other 
gross abnormalities.  A whole body 99m-Technicium bone scan was performed and 
needed to be negative for the presence of metastatic bony disease.  Signed 
informed consent was obtained from five participants.  This project received Human 
research ethics committee approval.  
 
Imaging details 
 
All MR examinations were performed on a GE 1.5 Tesla Signa Excite system using a 
lumbar phased-array coil.  Patients were positioned using a knee rest to minimise 
lumbar lordosis.  Initial scout images were followed by the dedicated In-phase and 
Out-of-phase imaging.  Specifically this was a T2-weighted iterative decomposition of 
water and fat with echo asymmetric and least squares estimation (IDEAL)-FSE 
sequence (TE/TR = 60 ms / 3000 ms).  This produced separate water-only and fat-
only images.  Twenty sagittal images of the spine from T10 to the mid-Sacrum were 
obtained using this approach for each patient, with a slice thickness of 3 mm. 
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DEXA scanning was performed on all individuals with individual readings from L2, L3 
and L4 vertebral bodies.  Z- and T-Scores were also calculated based on Australian 
data. 
 
Data Extraction 
 
Offline two independent observers (JM and WW) extracted data from the sagittal Fat 
T2 LINEAR images using proprietary software (Voyager Telerad Picture Archive and 
Communication System, Intellrad Solutions Pty Ltd, Melbourne, Australia).  A set 
protocol was followed with multiple observations.  The observers were instructed to 
begin at the sagittal slice 5 mm from cortical bone and to make freehand ROIs to 
provide measurements of vertebral fat content for all vertebral bodies within the field 
of view.  To limit peripheral artefact, the most superior and inferior vertebrae were 
not assessed.  Observers were instructed to exclude bony cortex, or any anatomical 
abnormalities observed on the T2 images.  They would then proceed from right to 
left on serial sagittal slices repeating the measurements five times overall.   
 
Magnetic Resonance Spectroscopy 
 
MR spectroscopy (MRS) was performed at the L3 level on all five patients. The 
software package SAGE (GE Medical Systems) was used to extract the areas under 
the peaks for separate fat and water peaks (Af and Aw respectively).  Fat fraction 
(FF) was calculated as Af / (Aw + Af ).  As this has very high correlation with FF using 
the LINEAR approach (r2 values of 0.85-0.9 3, 10), this figure was used to calculate a 
measurement for pure fat on the Fat T2 LINEAR images by dividing the measure 
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from the Fat LINEAR image at L3 by the FF figure from the MRS for the same 
vertebral body.  The FF for all other vertebrae were then calculated by dividing the 
Fat:LINEAR measure for that vertebra by the pure fat measure. 
 
Data Analysis 
 
Descriptive plots were constructed to assess for trends in observer variation as well 
as FF across adjacent vertebral bodies.  Linear regression was used to model the 
changes observed in FF within each participant.   
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Results 
 
Patient Characteristics 
 
Five men with locally advanced prostate cancer consented to this study.  All were 
aged between 70 and 75 years.  None was being treated with bisphosphonate 
therapy, corticosteroids or ADT, and none had a history of previous low trauma 
fracture or osteoporosis.  Figure 1 shows an example of a false colour LINEAR Fat 
MRI sagittal image. 
 
Reproducibility of Marrow Fat Fraction Measures 
 
To ensure stability of the FF measures, tests were done of intra- and inter-observer 
variation.  Between the two observers, 94 vertebral body Fat measurements were 
obtained, with a median of 5 observations per vertebral body.  A total of 464 
measurements were recorded.  For each observation, the percentage deviation from 
the mean for that vertebra and observer was calculated.  Figure 2 shows the 
percentage deviation of a single observation from the mean for a particular vertebral 
level and observer.  The overall average intra-observer variation was 3.4%, and in 
greater than 95% of instances, observations were within 9% of the mean.  No one 
patient’s vertebra had two separate measurements greater than 9% from the mean, 
nor was any individual deviation greater than 18%.  It was therefore concluded that 
there would be little effect from outliers on the data, and that the mean rather than 
the median would be a robust measure of data location. 
 
Page 10 
 
Similarly, inter-observer variation was compared across 45 different vertebral levels 
between the two observers.  The inter-observer percentage deviation was calculated 
as the absolute value for Observer A – Observer B divided by the average of the 
two.  Of the total of 45 observations, the overall average inter-observer variation was 
2.1%, with 21 of the vertebrae within 1% between the two observers, 33 within 3% 
and 39 within 5%.  The maximal variation was 8.1%.  This suggests that the reading 
protocol lead to consistent results within and between observers, and justified using 
a pooled mean value in the subsequent analyses. 
 
Fat Fraction 
 
Figure 3 shows FF at each vertebral level for each of the five patients.  Note that all 
show a gradual trend of increasing FF moving from the most rostral towards the 
most caudal vertebral body.  Table 1 quantifies the average differences in FF 
between adjacent vertebrae.   Note the anomaly in the trend that all patients show a 
reduced FF in S1 compared with L5.  This ‘L5-S1 Dip’ is noted in all five patients with 
figures of -4.9%, -6.1%, -2.4%, -7.0% and -1.6% respectively.  Due to one patient 
being shorter than the others, it was possible for a larger range of twelve vertebral 
bodies to be measured, and his FF per vertebrae is shown in Figure 4.  The trend of 
increasing FF moving inferiorly appears even more pronounced, with a 50.9% 
difference in FF seen between T10 (29.1%) and S4 (80.0%) seen.   
 
Fat Fraction Gradient 
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The gradient in FF was fitted to various models.  Given the possibility of other factors 
affecting FF measurements at S1, the models were trialled from T11 to L5.  For all 
five patients, a linear regression model proved a very good fit of the data, with R2 
values of between 0.81 and 0.96 (see Table 2).  More complex modelling offered 
only marginal improvements in the R2 over the linear model, and was usually 
inconsistent (eg quadratic model was convex for some patients, and concave for 
others).  The slope of the regression line varied from 1.1%/vertebra to 3.8%/vertebra 
(see Table 2).  Note how patients with similar L3 MRS FF readings can have 
different FF gradients.  Patients 1, 4 and 5 have L3 MRS FF of 34.8+/-1%, yet 
despite this similarity the FF gradient varies by a factor of 3.5 across the full range of 
observed FF gradient values for these 3 patients.  This suggests that a FF reading at 
a single vertebral level does not completely describe the functional marrow 
distribution. 
 
DEXA versus MRS FF 
 
The T-scores for the Lumbar vertebra were -2.1, -0.2, 2.3, -0.2 and 0.65, suggesting 
that 4 of the participants had normal BMD and one was osteopaenic.  The isolated 
DEXA BMD reading at L3 was compared with the MRS FF reading at the same 
vertebral level.  Only a weak negative correlation was noted between the two 
readings (R2=0.17).  One participant had a high MRS FF which was an outlier 
compared with the other four.  He was not the osteopaenic individual.  If the man 
with an abnormally high MRS FF was excluded, the negative correlation linear fit 
was much better (R2=0.57).  
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Discussion 
 
The use of LINEAR In:Out phase imaging, with ROI analysis, proved to be a rapid 
and reliable method for determination of vertebral FF. This method enables a large 
series of vertebral bodies to be measured following a single rapid acquisition. This 
contrasts with spectroscopy, which normally evaluates a single vertebra per 
acquisition. There was minimal inter- and intra-observer variation for these 
measurements for independent observers following our set protocol.  The most 
striking observation was that the more inferior the vertebral location, the more likely 
the FF would steadily increase.  This FF gradient appears to be largely independent 
of an isolated measure of FF using MRS at a single vertebral body level.  This result 
has not been reported using the LINEAR approach, but is in agreement with reports 
in the literature using MRS to estimated FF 2, 3.  
 
An early report touches on the possibility of a marrow gradient noting a trend toward 
increasing FF for more inferior vertebral bodies measured with MRS 3. In this study 
the mean FF value at L1 was 40.5%, and at L5 it was 51.3%, albeit with wide ranges 
due partially to only ten patients being examined in this manner.  This trend was not 
consistent, and may have been overwhelmed by the stronger relationships noted 
with both age and gender 4.  Even with these caveats, it is worth noting that the 
corresponding figures from our series were broadly similar at 37.7% and 46.7%.   
 
Another previous report again using MRS to quantify FF focussed on post-
menopausal women, which would be expected to reduce the impact of age and 
gender on the results 2.  Vertebral levels from L1 to L4 were all measured individually 
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for 40 women, some of whom were known to have low BMD.  The FF gradient 
increased by an average of 2.2%/vertebra moving inferiorly in the patients with low 
BMD, although no strong evidence of a gradient was seen in the healthy controls.  
The average figure in our series was 2.7%/vertebra, although only one of our five 
patients had a low BMD reading.   A subsequent report from the same group looking 
at diabetic women, also noted a trend towards reducing FF from L1 to L3 11. 
 
It would appear that our results using the LINEAR approach are consistent with 
earlier observations reported using MRS.  While the two approaches correlate well 
with each other, the latter is superior in its ability to examine more vertebral bodies 
simultaneously in a shorter time 3, 10.  Given the observed gradient in FF, it would 
seem that future investigators will either need to examine multiple vertebral bodies 
with MRS, or use an alternative approach such as LINEAR.   
 
There have been several reports suggesting a correlation between FF measured at a 
single vertebral body level and BMD measured by DEXA imaging 3, 5, 7.  However, 
there is extensive overlap between normal, osteopaenic and osteoporotic individuals.  
Part of the reason for this may be anatomical variations such as osteophytes which 
can interfere with DEXA readings 12, 13.  Although this might be circumvented with the 
use of qualitative CT, the increased radiation dose and lack of widely validated 
population data for this modality may curtail its widespread use 14.  Our hypothesis is 
that the complex functional anatomy, physiology and biology of bone is poorly 
captured using a single parameter such as Fat Fraction at a single vertebral level 15-
17.  Additional factors such as the FF gradient may be helpful in separated people 
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into distinct BMD categories, and as such this is an area that we are continuing to 
investigate. 
 
A second finding from our study was that there is a consistent reduction in FF 
moving from L5 to S1.  This contrasts with a result published using FLT-PET, 
although that study did not resolve to the same degree of anatomical precision as in 
the current report 6. This may be due to other subtle degenerative pathology at this 
level such as spondylosis relating to the unique mechanics of the L5-S1 joint 
compared with the more superior thoracic and lumbar articulations.  Further work will 
be required to clarify both the consistency of the reduction, as well as trying to gain a 
greater understanding of the underlying causes. If the FF does not change 
consistently and at an equal rate along the spine, individual measures by 
spectroscopy may miss changes.  
 
Loss of BMD is a common problem for men managed with ADT for prostate cancer 
18. This results in a higher rate of fractures for such men 19.  Previously, ADT was 
only used for men being managed palliatively for metastatic disease and hence with 
relatively low life expectancy.  Two key developments now make the long term 
toxicity of ADT more pertinent.  One is the evidence of efficacy of adjuvant ADT in 
the curative setting, meaning many men expecting to be cured of their prostate 
cancer will survive long enough to potentially experience the chronic effects of ADT 
exposure 20, 21.  The second is the increasing number of effective systemic therapies, 
extending the life of men in the metastatic setting 22.  Abiraterone Acetate in 
particular requires long term exposure to not only ADT, but also low dose 
prednisone, which would be expected to further accelerate loss of BMD 23. 
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Although our small study is in a relatively homogeneous patient population, we have 
demonstrated the potential to measure large regions of the spine revealing some 
consistent findings.  Following from the results from this study, we have initiated a 
larger prospective trial to investigate the capacity of lumbar spine MRI to predict 
which men are at higher risk of accelerated loss of BMD while on ADT as treatment 
for their prostate cancer.  Several randomized studies have shown improvements in 
BMD for unselected men on ADT treated with bisphosphonates, RANKL inhibition or 
selective oestrogen reuptake modulators 24.  Although there are numerous guidelines 
recommending pharmacological intervention for such men mainly on the basis of 
their T-score on DEXA imaging, given potential toxicities like osteonecrosis of the 
jaw as well as the expense of such agents there is scope to further target therapy to 
men most likely to benefit 24-26.   
 
Our current study focuses on men with prostate cancer being managed with curative 
intent with an 18 month course of ADT and pelvic radiotherapy.  Due to improved 
signal to noise ratio and shorter image acquisition time to reduce motion artefact, we 
will use a 3 Tesla system for this successor study 11.  We aim to investigate whether 
multiparametric MRI of the lumbar spine at baseline including both In:Out phase as 
well as diffusion weighted imaging might contribute to a model combined with clinical 
and DEXA findings to identify a subgroup of patients at risk of accelerated loss of 
BMD.   
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Conclusion 
 
Rapid acquisition of a large range of vertebral bodies with accurate determination of 
FF with ROI was demonstrated.  We have observed the existence of a gradient in 
Fat Fraction from T10 to S2.  There is also a consistent dip in Fat Fraction between 
L5 and S1, which may be due to the different anatomy and degenerative changes at 
this level.  These findings will be explored in a larger prospective study attempting to 
use such extra information available on MRI to determine which men are at risk of 
more rapid loss of BMD while on ADT. 
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Tables 
 
Table 1: Difference in Fat Fraction between adjacent vertebrae.  Note the steady 
increase at all levels except for L5-S1. 
 
Vertebra Fat Fraction Mean 
(Range) 
Difference 
T11 29.4% (19.7 – 36.9)  
T12 33.9% (25.1 – 44.5) 4.6% 
L1 37.6% (29.6 – 54.4) 3.7% 
L2 38.6% (32.7 – 54.2) 1.0% 
L3 40.0% (33.8 – 55.1) 1.4% 
L4 44.3% (36.3 – 58.7) 4.3% 
L5 46.6% (37.8 – 60.8) 2.3% 
S1 42.2% (31.5 – 58.5) -4.4% 
S2 47.9% (33.3 – 66.7) 5.7% 
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Table 2 
L3 MRS FF, with linear regression slope (an indicator of gradient in FF across the 
adjacent vertebral bodies) and R2 values.   
Patient MRS FF at 
L3 
FF Slope 
(FF%/vertebra) 
R2 
1 35.8 2.23 0.94 
2 41.2 2.74 0.82 
3 55.1 3.84 0.83 
4 34.2 1.10 0.81 
5 33.8 3.44 0.96 
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Figure Legends: 
Figure 1: Colour enhanced Fat T2 IDEAL sagittal image from a patient 
demonstrating vertebrae from T9 to S2.  Note how the more rostral vertebrae are 
generally more green coloured than the redder caudal vertebra suggesting 
increasing fat fraction moving rostrally 
Figure 2: Line graphs showing low intraobserver variation in Fat measurements. 
Figure 3: Fat fraction from T11 to S2 for the five patients measured.  Most patients 
demonstrate a trend of increasing fat fraction moving rostrally. 
Figure 4: The patient who due to his smaller size was able to have FF estimated for 
12 adjacent vertebral bodies showing a range of values of over 50% across the field 
of view. 
 
 
